As non-animal alternatives gain acceptance, a need for harmonised testing strategies has emerged. Arguably the most physiologically-relevant model for assessing potential respiratory toxicants, that based on human precision-cut lung slices (hPCLS) has been utilised in many laboratories, but a variety of culture methodologies are employed. In this pilot study, combinations of three different hPCLS culture methods (dynamic organ roller culture (DOC), air–liquid interface (ALI) and submersion) and various media (based on E-199, DMEM/F12 and RPMI-1640) were compared. The hPCLS were assessed in terms of their viability and responsiveness to challenge. The endpoints selected to compare the medium–method (M–M) combinations, which included histological features and viability, were evaluated at day 14 (D14) and day 28 (D28); protein and adenylate kinase (AK) content, and cytokine response to immunostimulants (lipopolysaccharide (LPS) at 5 μg/ml; polyinosinic:polycytidylic acid (Poly I:C) at 15 μg/ml) were evaluated at D28 only. Based on the set of endpoints assessed at D28, it was clear that certain culture conditions significantly affected the hPCLS, with the tissue retaining more of its native features and functionality (in terms of cytokine response) in some of the M–M combinations tested more than others. This pilot study indicates that the use of appropriate M–M combinations can help maintain the health and functional responses of hPCLS, and highlights the need for the standardisation of culture conditions in order to facilitate effective inter-laboratory comparisons and encourage greater acceptance by the regulatory community.
BeruBeKAufderheideMBrehenyD, et al.In vitro models of inhalation toxicity and disease. The report of a FRAME workshop. Altern Lab Anim2009; 37: 89–141.
2.
WilliamsKRomanJ. Studying human respiratory disease in animals — role of induced and naturally occurring models. J Pathol2016; 238: 220–232.
3.
MillerAJSpenceJR. In vitro models to study human lung development, disease and homeostasis. Physiology (Bethesda)2017; 32: 246–260.
4.
GkatzisKTaghizadehSHuhD, et al.Use of three-dimensional organoids and lung-on-a-chip methods to study lung development, regeneration and disease. Eur Respir J2018; 52: 1800876.
5.
LiKYangXXueC, et al.Biomimetic human lung-on-a-chip for modeling disease investigation. Biomicrofluidics2019; 13: 031501.
6.
CaoXCoyleJPXiongR, et al.Invited review: Human air–liquid-interface organotypic airway tissue models derived from primary tracheobronchial epithelial cells-overview and perspectives. Vitro Cell Dev Biol Anim2021; 57: 104–132.
7.
TannerLSingleAB. Animal models reflecting chronic obstructive pulmonary disease and related respiratory disorders: Translating pre-clinical data into clinical relevance. J Innate Immun2020; 12: 203–225.
8.
ParrishARGandolfiAJBrendelK. Precision-cut tissue slices: applications in pharmacology and toxicology. Life Sci1995; 57: 1887–1901.
9.
de KanterRMonshouwerMMeijerDK, et al.Precision-cut organ slices as a tool to study toxicity and metabolism of xenobiotics with special reference to non-hepatic tissues. Curr Drug Metab2002; 3: 39–59.
10.
SewaldKBraunA. Assessment of immunotoxicity using precision-cut tissue slices. Xenobiotica2013; 43: 84–97.
11.
BehrsingHHillECurrenR. Human precision-cut lung slices can provide important information to toxicologists. Appl In Vitro Toxicol2020; 6: 75–76.
12.
HerbertJGowA. Precision cut lung slices as a model for 3R application in toxicology. Appl In Vitro Toxicol2020; 6: 47–48.
13.
AlsafadiHNUhlFEPinedaRH, et al.Applications and approaches for three-dimensional precision-cut lung slices. Disease modeling and drug discovery. Am J Respir Cell Mol Biol2020; 62: 681–691.
14.
LiuGBettsCCunoosamyDM, et al.Use of precision cut lung slices as a translational model for the study of lung biology. Respir Res2019; 20: 162.
15.
MorinJPBasteJMGayA, et al.Precision cut lung slices as an efficient tool for in vitro lung physio-pharmacotoxicology studies. Xenobiotica2013; 43: 63–72.
16.
FisherRLSmithMSHasalSJ, et al.The use of human lung slices in toxicology. Hum Exp Toxicol1994; 13: 466–471.
17.
AlsafadiHNStaab-WeijnitzCALehmannM, et al.An ex vivo model to induce early fibrosis-like changes in human precision-cut lung slices. Am J Physiol Lung Cell Mol Physiol2017; 312: L896–L902.
18.
CedilakMBanjanacMBelamaricD, et al.Precision-cut lung slices from bleomycin treated animals as a model for testing potential therapies for idiopathic pulmonary fibrosis. Pulm Pharmacol Ther2019; 55: 75–83.
19.
WestraIMPhamBTGroothuisGM, et al.Evaluation of fibrosis in precision-cut tissue slices. Xenobiotica2013; 43: 98–112.
20.
HenjakovicMSewaldKSwitallaS, et al.Ex vivo testing of immune responses in precision-cut lung slices. Toxicol Appl Pharmacol2008; 231: 68–76.
21.
LauensteinLSwitallaSPrenzlerF, et al.Assessment of immunotoxicity induced by chemicals in human precision-cut lung slices (PCLS). Toxicol In Vitro2014; 28: 588–599.
22.
SwitallaSLauensteinLPrenzlerF, et al.Natural innate cytokine response to immunomodulators and adjuvants in human precision-cut lung slices. Toxicol Appl Pharmacol2010; 246: 107–115.
23.
TemannAGolovinaTNeuhausV, et al.Evaluation of inflammatory and immune responses in long-term cultured human precision-cut lung slices. Hum Vaccin Immunother2017; 13: 351–358.
24.
YilmazYWilliamsGWallesM, et al.Comparison of rat and human pulmonary metabolism using precision-cut lung slices (PCLS). Drug Metab Lett2019; 13: 53–63.
25.
JudeJBotelhoDKarmacharyaN, et al.Salicylic acid amplifies carbachol-induced bronchoconstriction in human precision-cut lung slices. Respir Res2019; 20: 72.
26.
JudeJKoziol-WhiteCScalaJ, et al.Formaldehyde induces Rho-associated kinase activity to evoke airway hyperresponsiveness. Am J Respir Cell Mol Biol2016; 55: 542–553.
27.
StegmayrJAlsafadiHNLangwinskiW, et al.Isolation of high-yield and -quality RNA from human precision-cut lung slices for RNA-sequencing and computational integration with larger patient cohorts. Am J Physiol Lung Cell Mol Physiol2021; 320: L232–L240.
28.
NeuhausVSchwarzKKleeA, et al.Functional testing of an inhalable nanoparticle based influenza vaccine using a human precision cut lung slice technique. PLoS One2013; 8: e71728.
29.
BaiYKrishnamoorthyNPatelKR, et al.Cryopreserved human precision-cut lung slices as a bioassay for live tissue banking. A viability study of bronchodilation with bitter-taste receptor agonists. Am J Respir Cell Mol Biol2016; 54: 656–663.
30.
NeuhausVSchaudienDGolovinaT, et al.Assessment of long-term cultivated human precision-cut lung slices as an ex vivo system for evaluation of chronic cytotoxicity and functionality. J Occup Med Toxicol2017; 12: 13.
31.
BaileyKEPinoCLennonML, et al.Embedding of precision-cut lung slices in engineered hydrogel biomaterials supports extended ex vivo culture. Am J Respir Cell Mol Biol2020; 62: 14–22.
32.
LiGCohenJAMartinesC, et al.Preserving airway smooth muscle contraction in precision-cut lung slices. Sci Rep2020; 10: 6480.
33.
CalabreseVCorneliusCDinkova-KostovaAT, et al.Cellular stress responses, the hormesis paradigm, and vitagenes: Novel targets for therapeutic intervention in neurodegenerative disorders. Antioxid Redox Signal2010; 13: 1763–1811.
34.
SgallaGIoveneBCalvelloM, et al.Idiopathic pulmonary fibrosis: Pathogenesis and management. Respir Res2018; 19: 32.
BarnesPJ. Small airways in COPD. N Engl J Med2004; 350: 2635–2637.
39.
BarnesPJ. Cellular and molecular mechanisms of chronic obstructive pulmonary disease. Clin Chest Med2014; 35: 71–86.
40.
OjoOLaganALRajendranV, et al.Pathological changes in the COPD lung mesenchyme — Novel lessons learned from in vitro and in vivo studies. Pulm Pharmacol Ther2014; 29: 121–128.
41.
PostmaDSReddelHKten HackenNH, et al.Asthma and chronic obstructive pulmonary disease: Similarities and differences. Clin Chest Med2014; 35: 143–156.
42.
SiafakasNMAntoniouKMTzortzakiEG. Role of angiogenesis and vascular remodeling in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis2007; 2: 453–462.
